FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1969281636> ?p ?o ?g. }

• W1969281636 endingPage "e5052" @default.
• W1969281636 startingPage "e5052" @default.
• W1969281636 abstract "Background Lung adenocarcinoma is the leading cause of cancer-related deaths among both men and women in the world. Despite recent advances in diagnosis and treatment, the mortality rates with an overall 5-year survival of only 15%. This high mortality is probably attributable to early metastasis. Although several well-known markers correlated with poor/metastasis prognosis in lung adenocarcinoma patients by immunohistochemistry was reported, the molecular mechanisms of lung adenocarcinoma development are still not clear. To explore novel molecular markers and their signaling pathways will be crucial for aiding in treatment of lung adenocarcinoma patients. Methodology/Principal Findings To identify novel lung adenocarcinoma-associated /metastasis genes and to clarify the underlying molecular mechanisms of these targets in lung cancer progression, we created a bioinformatics scheme consisting of integrating three gene expression profile datasets, including pairwise lung adenocarcinoma, secondary metastatic tumors vs. benign tumors, and a series of invasive cell lines. Among the novel targets identified, FLJ10540 was overexpressed in lung cancer tissues and is associated with cell migration and invasion. Furthermore, we employed two co-expression strategies to identify in which pathway FLJ10540 was involved. Lung adenocarcinoma array profiles and tissue microarray IHC staining data showed that FLJ10540 and VEGF-A, as well as FLJ10540 and phospho-AKT exhibit positive correlations, respectively. Stimulation of lung cancer cells with VEGF-A results in an increase in FLJ10540 protein expression and enhances complex formation with PI3K. Treatment with VEGFR2 and PI3K inhibitors affects cell migration and invasion by activating the PI3K/AKT pathway. Moreover, knockdown of FLJ10540 destabilizes formation of the P110-α/P85-α-(PI3K) complex, further supporting the participation of FLJ10540 in the VEGF-A/PI3K/AKT pathway. Conclusions/Significance This finding set the stage for further testing of FLJ10540 as a new therapeutic target for treating lung cancer and may contribute to the development of new therapeutic strategies that are able to block the PI3K/AKT pathway in lung cancer cells." @default.
• W1969281636 created "2016-06-24" @default.
• W1969281636 creator A5005204397 @default.
• W1969281636 creator A5006822373 @default.
• W1969281636 creator A5012264926 @default.
• W1969281636 creator A5014314211 @default.
• W1969281636 creator A5034939465 @default.
• W1969281636 creator A5038296232 @default.
• W1969281636 creator A5042791635 @default.
• W1969281636 creator A5044968009 @default.
• W1969281636 creator A5048669688 @default.
• W1969281636 creator A5049040142 @default.
• W1969281636 creator A5085459927 @default.
• W1969281636 creator A5089158634 @default.
• W1969281636 date "2009-04-01" @default.
• W1969281636 modified "2023-10-14" @default.
• W1969281636 title "VEGFA Upregulates FLJ10540 and Modulates Migration and Invasion of Lung Cancer via PI3K/AKT Pathway" @default.
• W1969281636 cites W1512809401 @default.
• W1969281636 cites W1973890143 @default.
• W1969281636 cites W1974007392 @default.
• W1969281636 cites W1986099901 @default.
• W1969281636 cites W1995280612 @default.
• W1969281636 cites W1997040978 @default.
• W1969281636 cites W2001658518 @default.
• W1969281636 cites W2003429634 @default.
• W1969281636 cites W2009812837 @default.
• W1969281636 cites W2012339210 @default.
• W1969281636 cites W2014169920 @default.
• W1969281636 cites W2016241489 @default.
• W1969281636 cites W2019098044 @default.
• W1969281636 cites W2020830322 @default.
• W1969281636 cites W2034269086 @default.
• W1969281636 cites W2034935605 @default.
• W1969281636 cites W2038056833 @default.
• W1969281636 cites W2043103956 @default.
• W1969281636 cites W2047246023 @default.
• W1969281636 cites W2056774966 @default.
• W1969281636 cites W2060346337 @default.
• W1969281636 cites W2066039014 @default.
• W1969281636 cites W2070732456 @default.
• W1969281636 cites W2071531606 @default.
• W1969281636 cites W2078083828 @default.
• W1969281636 cites W2080178684 @default.
• W1969281636 cites W2083714459 @default.
• W1969281636 cites W2086641174 @default.
• W1969281636 cites W2092647993 @default.
• W1969281636 cites W2092736758 @default.
• W1969281636 cites W2093390390 @default.
• W1969281636 cites W2093953040 @default.
• W1969281636 cites W2094543320 @default.
• W1969281636 cites W2095143806 @default.
• W1969281636 cites W2098334616 @default.
• W1969281636 cites W2099461384 @default.
• W1969281636 cites W2104516860 @default.
• W1969281636 cites W2109181262 @default.
• W1969281636 cites W2114311689 @default.
• W1969281636 cites W2118411779 @default.
• W1969281636 cites W2121300496 @default.
• W1969281636 cites W2123642928 @default.
• W1969281636 cites W2130044050 @default.
• W1969281636 cites W2158751174 @default.
• W1969281636 cites W2161235995 @default.
• W1969281636 cites W2169965478 @default.
• W1969281636 doi "https://doi.org/10.1371/journal.pone.0005052" @default.
• W1969281636 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2659802" @default.
• W1969281636 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19337377" @default.
• W1969281636 hasPublicationYear "2009" @default.
• W1969281636 type Work @default.
• W1969281636 sameAs 1969281636 @default.
• W1969281636 citedByCount "110" @default.
• W1969281636 countsByYear W19692816362012 @default.
• W1969281636 countsByYear W19692816362013 @default.
• W1969281636 countsByYear W19692816362014 @default.
• W1969281636 countsByYear W19692816362015 @default.
• W1969281636 countsByYear W19692816362016 @default.
• W1969281636 countsByYear W19692816362017 @default.
• W1969281636 countsByYear W19692816362018 @default.
• W1969281636 countsByYear W19692816362019 @default.
• W1969281636 countsByYear W19692816362020 @default.
• W1969281636 countsByYear W19692816362021 @default.
• W1969281636 countsByYear W19692816362022 @default.
• W1969281636 countsByYear W19692816362023 @default.
• W1969281636 crossrefType "journal-article" @default.
• W1969281636 hasAuthorship W1969281636A5005204397 @default.
• W1969281636 hasAuthorship W1969281636A5006822373 @default.
• W1969281636 hasAuthorship W1969281636A5012264926 @default.
• W1969281636 hasAuthorship W1969281636A5014314211 @default.
• W1969281636 hasAuthorship W1969281636A5034939465 @default.
• W1969281636 hasAuthorship W1969281636A5038296232 @default.
• W1969281636 hasAuthorship W1969281636A5042791635 @default.
• W1969281636 hasAuthorship W1969281636A5044968009 @default.
• W1969281636 hasAuthorship W1969281636A5048669688 @default.
• W1969281636 hasAuthorship W1969281636A5049040142 @default.
• W1969281636 hasAuthorship W1969281636A5085459927 @default.
• W1969281636 hasAuthorship W1969281636A5089158634 @default.
• W1969281636 hasBestOaLocation W19692816361 @default.
• W1969281636 hasConcept C121608353 @default.
• W1969281636 hasConcept C126322002 @default.

• next